studyid,domain,usubjid,aeseq,aespid,aeterm,aellt,aelltcd,aedecod,aeptcd,aehlt,aehltcd,aehlgt,aehlgtcd,aecat,aescat,aepresp,aebodsys,aebdsycd,aesoc,aesoccd,aeser,aeacn,aerel,aeout,aesdth,aeshosp,epoch,aestdtc,aeendtc,aestdy,aeendy
A0001,AE,A0001-0002,1,FU01,Diarrhea,Diarrhea,10012727,Diarrhoea,10012735,Diarrhoea (excl infective),10012736,Gastrointestinal motility and defaecation conditions,10017977,FOLLOW-UP,OTHER ADVERSE EVENTS ON UPTRAVI,NULL,Gastrointestinal disorders,10017947,Gastrointestinal disorders,10017947,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
A0001,AE,A0001-0002,2,ME-U02,Diarrhea,Diarrhea,10012727,Diarrhoea,10012735,Diarrhoea (excl infective),10012736,Gastrointestinal motility and defaecation conditions,10017977,MEDICATION,UPTRAVI TREATMENT,NULL,Gastrointestinal disorders,10017947,Gastrointestinal disorders,10017947,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
A0001,AE,A0001-0002,3,FU01,Headache,Headache,10019211,Headache,10019211,Headaches NEC,10019233,Headaches,10019231,FOLLOW-UP,OTHER ADVERSE EVENTS ON UPTRAVI,NULL,Nervous system disorders,10029205,Nervous system disorders,10029205,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
A0001,AE,A0001-0002,4,ME-U02,Headache,Headache,10019211,Headache,10019211,Headaches NEC,10019233,Headaches,10019231,MEDICATION,UPTRAVI TREATMENT,NULL,Nervous system disorders,10029205,Nervous system disorders,10029205,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
A0001,AE,A0001-0001,1,ME-U02,PAH disease progression,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,MEDICATION,OTHER PAH-SPECIFIC THERAPY,Y,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
A0001,AE,A0001-0001,2,ME-U03,PAH disease progression,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,MEDICATION,OTHER PAH-SPECIFIC THERAPY,Y,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
